A phase 2 open-label trial evaluated transdermal CBD for 22q11.2 deletion syndrome in children, demonstrating tolerability with preliminary behavioral improvements. While promising for this rare genetic condition, controlled trials are needed to establish definitive therapeutic benefits before clinical implementation.
Medical Use of Cannabis Poses Risks in Adolescents – Medscape
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Adolescent MedicineNeurodevelopmentCbdThcPediatrics Why This MattersAdolescent brain development continues through age 25, making this population...
Does Weed Stunt Penis Growth? What the Evidence Actually Shows
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Adolescent HealthReproductive HealthCannabis DevelopmentHormonesPediatrics Why This MattersThis question reflects widespread concern among adolescent patients...
Mother sentenced after pressuring child into taking THC gummies – WOWT
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Pediatric MedicineLegal IssuesThcPatient SafetyMedical Cannabis Why This MattersThis case highlights the critical distinction between...
Can medicinal cannabis help kids’ autism, ADHD or Tourette’s? Here’s what we know so far
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. NeurologyPediatricsResearchSafety Why This Matters Clinicians caring for children with autism, ADHD, or Tourette syndrome need...
Can medicinal cannabis help kids’ autism, ADHD or Tourette’s? Here’s what we know so far
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PediatricNeurodevelopmentalAutismAdhdSafety Why This MattersPediatric cannabis use for neurodevelopmental conditions represents one of the most...
Marijuana Rescheduling Could ‘Unlock Research’ To Treat Rare Diseases, Father Of …
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Rare DiseasesPediatric MedicineResearch PolicyEpilepsyClinical Trials Why This MattersDEA rescheduling from Schedule I to Schedule...